## Introduction
Psychotic and [neurodevelopmental disorders](@entry_id:189578), exemplified by [schizophrenia](@entry_id:164474) and Autism Spectrum Disorder (ASD), represent some of the most complex and challenging conditions in modern medicine. Their profound impact on perception, cognition, and social function has driven a concerted effort within neuroscience to uncover their biological roots. While clinical descriptions provide a necessary starting point, a deeper understanding requires moving beyond symptomatology to explore the underlying genetic, cellular, and circuit-level disruptions. This article addresses the need for an integrated framework that connects findings from disparate fields—from genetics and developmental biology to computational modeling—into a coherent narrative of how these disorders arise and manifest.

This article will guide you through a multi-level exploration of these conditions. You will begin by examining the core neurobiological concepts in **"Principles and Mechanisms,"** which deconstructs these disorders into fundamental dimensions of genetic risk, synaptic pathophysiology, and systems-level dysfunction. Next, in **"Applications and Interdisciplinary Connections,"** you will see how these foundational principles are put into practice to refine diagnosis, guide drug development, and build testable computational models of brain function. Finally, the **"Hands-On Practices"** section will provide opportunities to engage directly with these concepts through quantitative exercises in pharmacology, circuit modeling, and cognitive science. This structured journey will equip you with a principled, mechanistic understanding of the [neurobiology](@entry_id:269208) of psychotic and neurodevelopmental disorders.

## Principles and Mechanisms

This chapter delves into the fundamental principles and neurobiological mechanisms currently understood to underlie psychotic and neurodevelopmental disorders, with a primary focus on schizophrenia and Autism Spectrum Disorder (ASD). Moving beyond the introductory clinical descriptions, we will explore the genetic architecture, cellular and synaptic pathophysiology, and systems-level dysfunction that characterize these conditions. Our approach will be to build from foundational concepts of diagnosis and [heritability](@entry_id:151095) towards the intricate details of [brain development](@entry_id:265544), neurochemistry, and circuit function, culminating in an examination of powerful computational models that aim to unify these different levels of analysis.

### From Categorical Diagnoses to Dimensional Spectra

Historically, psychiatric conditions like schizophrenia were treated as distinct, categorical entities. An individual either had the disorder or did not. However, contemporary clinical neuroscience increasingly conceptualizes these conditions as existing on a **spectrum**, reflecting continuous underlying dimensions of risk or liability in the general population.

A formal framework for this idea is the **[liability-threshold model](@entry_id:154597)**. This model posits a latent, continuously distributed liability, $L$, which is typically assumed to follow a normal distribution in the population. This liability represents an individual's total integrated risk, arising from genetic and environmental factors. A categorical diagnosis is made only when an individual's liability $L$ exceeds a certain critical threshold, $c$. This model elegantly bridges the apparent contradiction between a continuous distribution of risk factors in the population and the categorical nature of a clinical diagnosis [@problem_id:5054332].

This spectrum perspective has profound implications for research. Treating a complex phenotype like schizophrenia simply as a binary category (case vs. control) can lead to a loss of statistical power, as it discards the rich variance that exists below the diagnostic threshold. When the relationship between a risk factor and a symptom dimension is approximately linear, analyzing the full continuous range of that dimension across the entire population, rather than using a dichotomized diagnostic group, can provide a more sensitive and powerful test of association [@problem_id:5054332] [@problem_id:5054383].

To operationalize this dimensional approach, it is crucial to deconstruct complex diagnoses into more fundamental **symptom dimensions**.
*   In **psychosis**, a syndrome characterized by impaired reality testing, three core dimensions are recognized:
    1.  **Positive symptoms** represent an excess or distortion of normal functions, such as **hallucinations** (perceptual experiences without external stimuli) and **delusions** (fixed, false beliefs).
    2.  **Negative symptoms** represent a diminution of normal functions, including **avolition** (lack of motivation), **anhedonia** (inability to feel pleasure), and **alogia** (poverty of speech).
    3.  **Disorganization** reflects formal thought disorder, disorganized speech, and bizarre behavior.
*   In **Autism Spectrum Disorder (ASD)**, the core diagnostic criteria cluster into two dimensions:
    1.  **Social-communication deficits**, including difficulties with social-emotional reciprocity and nonverbal communication.
    2.  **Restricted, repetitive patterns of behavior, interests, or activities (RRBs)**, such as motor stereotypies, insistence on sameness, and circumscribed interests.

Importantly, **[schizophrenia](@entry_id:164474)** itself is a specific diagnostic category within the broader psychosis spectrum. It is defined not only by the presence of characteristic symptoms (e.g., from the positive, negative, and disorganization domains) but also by criteria for duration (at least six months), significant functional impairment, and the exclusion of other medical, substance-induced, or psychiatric (e.g., primary mood disorder) causes for the psychosis [@problem_id:5054332].

A key advantage of a dimensional, cross-diagnostic approach is the ability to map symptoms onto underlying [neurobiology](@entry_id:269208), regardless of the overarching diagnosis. For instance, research suggests that the disorganization dimension in psychosis and the RRB dimension in ASD may share a common substrate in cognitive inflexibility, linked to dysfunction in the **dorsolateral prefrontal cortex (DLPFC)** and associated frontoparietal networks that support executive functions like set-shifting. Similarly, negative symptoms in psychosis and social-communication deficits in ASD may both be linked to impairments in social cognition (e.g., theory of mind) and reward processing, implicating circuits involving the **medial prefrontal cortex (mPFC)** and **ventral striatum** [@problem_id:5054389].

### The Genetic Architecture and the Search for Endophenotypes

Both schizophrenia and ASD are highly heritable. Understanding their genetic basis is a central goal of modern psychiatry, but it presents significant challenges. The total [phenotypic variance](@entry_id:274482) ($V_P$) of a trait can be decomposed into genetic ($V_G$) and environmental ($V_E$) components. The genetic variance can be further subdivided into additive ($V_A$), dominance ($V_D$), and epistatic ($V_I$) variance.

**Narrow-sense heritability**, denoted $h^2$, is the proportion of total phenotypic variance attributable to additive genetic variance: $h^2 = V_A / V_P$. This value is crucial because it determines the degree to which a trait is passed from parent to offspring and the potential response to selection. Family, twin, and adoption studies have established that the [heritability](@entry_id:151095) of liability for schizophrenia is high, often estimated around $0.80$.

Genome-wide association studies (GWAS) have identified numerous genetic loci associated with these disorders. These studies allow for the estimation of **SNP [heritability](@entry_id:151095)** ($h^2_{\text{SNP}}$), which is the proportion of phenotypic variance explained by the additive effects of all common [single nucleotide polymorphisms](@entry_id:173601) (SNPs) measured in the study. Typically, $h^2_{\text{SNP}}$ is substantially lower than $h^2$ from [twin studies](@entry_id:263760), a gap often referred to as "[missing heritability](@entry_id:175135)." This discrepancy arises because GWAS primarily captures common variants and may miss the contribution of rare variants, structural variations, and complex gene-[gene interactions](@entry_id:275726) (epistasis). Importantly, heritability is not a biological constant; it can change depending on the environmental context, leading to the concept of **environment-specific heritability**, $h^2(E)$, which reflects gene-by-environment interactions [@problem_id:5054383].

When estimating heritability for binary traits like schizophrenia from case-control studies, careful statistical correction is required. Such studies intentionally oversample cases relative to their population prevalence ($K$). This **ascertainment** process means the sample is not random and the variance of the binary outcome in the sample ($P(1-P)$, where $P$ is the case proportion) differs from that in the population ($K(1-K)$). To translate heritability estimated on this observed scale to the more meaningful liability scale, a transformation is needed that accounts for both $K$ and $P$. Without this correction, estimates are biased [@problem_id:5054383].

Given the vast genetic complexity, researchers often seek **endophenotypes**—heritable, [quantitative traits](@entry_id:144946) that are thought to be intermediate on the causal pathway from genes to the clinical syndrome. To qualify as an endophenotype, a trait must meet several criteria [@problem_id:5054377]:
1.  **Association with Illness**: It must be associated with the disorder in the population.
2.  **Heritability**: It must be heritable, as indicated for example by higher correlations in monozygotic twins ($r_{MZ}$) than dizygotic twins ($r_{DZ}$).
3.  **State-Independence**: It must be a stable trait, not a fluctuating symptom of the acute illness state. This is evidenced by high test-retest reliability and weak correlation with symptom severity.
4.  **Familial Co-segregation**: Within families affected by the illness, the endophenotype should be more prominent in ill members and also be present to an intermediate degree in their unaffected first-degree relatives compared to the general population.

Working [memory performance](@entry_id:751876), for example, is a strong candidate for an endophenotype in schizophrenia. Consistent findings show that patients are impaired, their unaffected siblings show intermediate deficits, the trait is heritable, and the deficit is stable over time regardless of whether a patient is in an acute or remitted phase of the illness. Such endophenotypes provide a more tractable target for genetic studies than the complex clinical diagnosis itself [@problem_id:5054377].

### Neurodevelopmental Pathways: Critical Periods and Synaptic Pruning

Schizophrenia and ASD are fundamentally **neurodevelopmental disorders**. Their origins are believed to lie in aberrant processes of brain development that occur long before the full clinical syndrome emerges.

A key concept in developmental neurobiology is the **critical period**: a time-limited window during which experience can powerfully shape and reorganize neural circuits. The opening and closing of these periods are tightly regulated biological processes. A critical period typically opens when inhibitory circuitry, particularly involving fast-spiking **[parvalbumin](@entry_id:187329)-positive (PV) interneurons**, matures to a point where it can provide the precise temporal gating needed for effective, activity-dependent synaptic plasticity. The period closes when structural elements, most notably **[perineuronal nets](@entry_id:162968) (PNNs)**—specialized extracellular matrix structures that enwrap PV cells—accumulate and stabilize existing synapses, restricting further large-scale remodeling [@problem_id:5054388].

Alterations in the timing of these critical periods may represent a fundamental divergence point in the developmental pathways leading to different disorders:
*   **ASD-like phenotypes** may be associated with a premature closure of [critical periods](@entry_id:171346). An accelerated maturation of inhibitory circuits and early PNN formation could truncate the window for experience-dependent learning. This might result in circuitry that is rigid and overly specialized for early sensory inputs, potentially explaining the insistence on sameness, restricted interests, and sensory hypersensitivity characteristic of ASD [@problem_id:5054388].
*   **Psychosis-spectrum phenotypes**, conversely, may be linked to a failure of critical periods to close properly. Deficits in PV interneuron function and insufficient PNN deposition could lead to a protracted state of circuit immaturity and instability. This persistent, poorly regulated plasticity could leave the brain vulnerable to aberrant circuit formation later in life, particularly during the dynamic synaptic reorganization of adolescence, contributing to the emergence of psychosis [@problem_id:5054388].

One of the most crucial processes occurring during these developmental windows is **synaptic pruning**, the activity-dependent elimination of unnecessary or weaker synapses. This process is essential for refining cortical circuits and enhancing their efficiency. Recent evidence has implicated the brain's resident immune cells, **microglia**, and components of the **complement system** as key actors in pruning [@problem_id:5054369]. In this mechanism, complement proteins, such as C1q and C3, "tag" synapses destined for removal. Microglia, which express complement receptor 3 (CR3), recognize these tags and engulf the synapse.

Genetic findings have powerfully linked this process to [schizophrenia](@entry_id:164474). Large-scale GWAS identified the strongest [genetic association](@entry_id:195051) for schizophrenia within the [major histocompatibility complex](@entry_id:152090) (MHC) locus, specifically implicating alleles that lead to higher expression of **complement component 4A (C4A)**. The hypothesized mechanism is that elevated C4A levels lead to excessive complement deposition on synapses, particularly during the crucial period of adolescent brain maturation. This, in turn, may trigger over-aggressive pruning by microglia, resulting in an abnormal loss of excitatory synapses and reduced [dendritic spine](@entry_id:174933) density. This excessive [synaptic elimination](@entry_id:200432) in key cortical areas like the prefrontal cortex is a leading hypothesis for the cortical thinning and cognitive deficits observed in [schizophrenia](@entry_id:164474) [@problem_id:5054369].

### Core Pathophysiology: Neurotransmitters and Circuit Imbalance

The neurodevelopmental disruptions described above culminate in the circuit-level pathophysiology that more directly produces symptoms in adulthood. Three major hypotheses have dominated research on [schizophrenia](@entry_id:164474), and they are now viewed as highly interconnected.

1.  **The Dopamine Hypothesis:** The oldest hypothesis posits that positive symptoms of psychosis arise from **hyperdopaminergia**, specifically an excess of dopamine signaling in the [mesolimbic pathway](@entry_id:164126). This is strongly supported by the fact that all effective [antipsychotic drugs](@entry_id:198353) are antagonists at the **dopamine D2 receptor**. Positron Emission Tomography (PET) studies have established a therapeutic window for these drugs: antipsychotic efficacy is typically achieved when D2 receptor occupancy is between $65\%$ and $80\%$. Occupancy above $\sim80\%$ significantly increases the risk of motor side effects (extrapyramidal symptoms) due to blockade of D2 receptors in the nigrostriatal pathway. Further evidence comes from PET studies showing increased presynaptic [dopamine synthesis](@entry_id:172942) capacity in individuals with schizophrenia, consistent with a hyperdopaminergic state [@problem_id:5054301].

2.  **The Glutamate Hypothesis:** This hypothesis proposes that [schizophrenia](@entry_id:164474) involves **hypofunction of the N-methyl-D-aspartate (NMDA) receptor**, a critical type of [glutamate receptor](@entry_id:164401). Evidence comes from the observation that NMDA receptor antagonists like phencyclidine (PCP) and ketamine can induce the full range of positive, negative, and cognitive symptoms of schizophrenia in healthy individuals. A key insight is that NMDA receptors are particularly crucial for the function of GABAergic interneurons. Therefore, NMDA receptor hypofunction on these interneurons is thought to lead to their failure, resulting in **cortical [disinhibition](@entry_id:164902)**—a loss of inhibitory control over pyramidal neurons. This disinhibition can cause chaotic firing and downstream dysregulation of other [neurotransmitter systems](@entry_id:172168), including dopamine [@problem_id:5054301].

3.  **The GABAergic Interneuron Deficit Hypothesis:** Converging lines of evidence point to a core deficit in **GABAergic interneurons**, especially the fast-spiking, PV-expressing basket cells. Postmortem studies consistently find reductions in the expression of GAD67 (the enzyme that synthesizes GABA) and [parvalbumin](@entry_id:187329) (PV) in the cortex of individuals with [schizophrenia](@entry_id:164474). As these PV interneurons are essential for generating synchronized network activity, their impairment has profound consequences for cortical information processing [@problem_id:5054301].

These three hypotheses are not mutually exclusive; they form a unified picture. A primary deficit in NMDA receptor signaling on PV interneurons ([glutamate hypothesis](@entry_id:198112)) leads to impaired interneuron function (GABA hypothesis), which causes cortical disinhibition. This chaotic cortical output can, in turn, drive hyperactivity of midbrain dopamine neurons, leading to mesolimbic hyperdopaminergia ([dopamine hypothesis](@entry_id:183447)).

The principle of **excitation-inhibition (E/I) balance** is also central to understanding ASD. Many theories of ASD propose a shift in this balance, often towards excess excitation or, equivalently, reduced inhibition. This can mechanistically explain the phenomenon of sensory hypersensitivity. Cortical circuits use inhibition for **gain control** and **population normalization**, processes that adjust the responsiveness of neurons and scale their output relative to the overall activity in the local network. Reduced GABAergic inhibition weakens this normalization, causing individual neurons to fire at abnormally high rates in response to input. This elevated neuronal gain leads to amplified responses to sensory stimuli. While this may enhance the processing of local details, it degrades the coordination of activity across distributed neuronal populations, which is necessary for global integration of information [@problem_id:5054326].

### Systems-Level Dysfunction: Oscillations and Predictive Coding

The cellular and synaptic abnormalities discussed previously manifest at the systems level as disruptions in coordinated brain activity, which can be measured as **neural oscillations** using EEG or MEG. Different frequency bands of oscillations are associated with distinct cognitive functions:

*   **Gamma oscillations** ($30$–$80\,\mathrm{Hz}$) are generated by the fast-paced interaction between pyramidal cells and PV interneurons. Gamma-band synchrony is thought to be a key mechanism for "binding" features into a coherent percept and for maintaining information in working memory.
*   **Beta oscillations** ($13$–$30\,\mathrm{Hz}$) are associated with longer-range communication, particularly in cortico-basal ganglia loops, and are involved in top-down cognitive control and maintaining the current sensorimotor or cognitive state.
*   **Alpha oscillations** ($8$–$12\,\mathrm{Hz}$) are prominent in posterior cortex at rest and are generated by thalamocortical circuits. They are thought to play a role in sensory gating by actively inhibiting processing in task-irrelevant regions.

In [schizophrenia](@entry_id:164474), deficits in PV interneuron function lead directly to reduced power and **phase coherence** (temporal alignment) of **gamma oscillations**, particularly during demanding cognitive tasks like working memory. This provides a direct systems-level explanation for the profound cognitive deficits in the disorder. In ASD, the pattern can be different, with some studies showing increased local gamma power (reflecting local hyperexcitability) but reduced long-range gamma coherence, consistent with a failure of large-scale integration. Both disorders also show alterations in other bands, such as reduced beta coherence during cognitive control tasks and abnormal posterior alpha activity, reflecting altered thalamocortical sensory gating [@problem_id:5054310].

Finally, **[computational psychiatry](@entry_id:187590)** offers a powerful theoretical framework that can unify many of these disparate findings. One of the most influential frameworks is **[predictive coding](@entry_id:150716)**, which models the brain as a hierarchical Bayesian inference machine. In this model, higher levels of the cortical hierarchy generate top-down predictions about the causes of sensory input. These predictions are compared with bottom-up sensory signals at lower levels, and only the discrepancy—the **prediction error**—is passed up the hierarchy. This process continuously updates the brain's internal model of the world to minimize future prediction errors [@problem_id:5054304].

Crucially, the influence of top-down predictions (the **prior**) versus bottom-up sensory data (the **likelihood**) is modulated by their relative **precision** (the inverse of variance, or confidence). This **precision-weighting** acts as a form of gain control on prediction errors. Aberrant precision-weighting can provide a compelling explanation for core symptoms of both [schizophrenia](@entry_id:164474) and ASD:

*   **Hallucinations in Schizophrenia:** These may arise from an imbalance where the **precision of prior beliefs is abnormally high**. In this state, top-down predictions become overly influential and can dominate perception, even in the absence of supporting sensory evidence. The brain literally perceives what it expects to perceive, generating a hallucinatory experience [@problem_id:5054304].

*   **Sensory Symptoms in ASD:** Conversely, many sensory symptoms in ASD can be explained by **abnormally low precision of priors** (or "hypopriors"). In this scenario, the brain fails to use context or past experience to appropriately filter or attenuate sensory input. As a result, bottom-up prediction errors are given excessive weight, leading to a volatile, intense, and overwhelming perceptual world that is not "smoothed out" by top-down expectations. This aligns with descriptions of sensory overload and a painful perception of unfiltered detail [@problem_id:5054304].

This computational framework provides a unifying syntax for describing how the E/I imbalances, synaptic deficits, and oscillatory dysrhythmias discussed throughout this chapter can ultimately give rise to the subjective experiences that define these complex and challenging disorders.